gastric cancer

envie a um amigo share this

Anti-HER2 therapies and gastric cancer


Ramon Andrade de Mello, MD, PhD ,1 - Serviço de Oncologia Médica - IPO do Porto 2 - Departamento de Medicina, Faculdade de Medicina da Universidade do Porto, Porto 3 - Departamento de Ciências Biomédicas e Medicina, Universidade do Algarve, Faro

Genomic study of gastric cancer involving a portuguese-chinese consortium

The Coimbra Genomics S.A., a company dedicated to the emergent field of genomics, jointly with IPATIMUP and the Chinese organization BGI are lauching a research project aiming to understand the genetic basis of gastric carcinoma.

Family Aggregation of Gastric Cancer: Risk Phenotypic and genotypic

Authors and affiliations:

Ricardo Marcos-Pinto1,2,3,4, Mário Dinis-Ribeiro4,6, Fátima Carneiro3,5, Xiaogang Wen5, Carlos Lopes7,1, Céu Figueiredo3,5, José Carlos Machado3,5, Rui Ferreira3, Celso A. Reis1,3,5, José Ferreira2, Isabel Pedroto1,2, Jorge Areias1,2

 

1. Institute of Biomedical Sciences, University of Porto (ICBAS/UP), Porto, Portugal

Gastric Cancer: adding glycosylation to the equation

Authors and affiliations:

Salomé S. Pinho1,2, Sandra Carvalho1,2, Ricardo Marcos-Pinto2,3, Ana Magalhaes1, Carla Oliveira1,4, Jianguo Gu5, Mário Dinis-Ribeiro6,7, Fátima Carneiro1,4,8, Raquel Seruca1,4, and Celso A. Reis1,2,4

1 Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Rua Dr Roberto Frias s/n, 4200-465 Porto, Portugal

2 Institute of Biomedical Sciences of Abel Salazar (ICBAS), University of Porto, Rua de Jorge Viterbo Ferreira n.8 228, 4050-313 Porto, Portugal

Gastric Cancer: adding glycosylation to the equation

O cancro gástrico apresenta uma alta incidência e mortalidade, sendo necessário compreender os mecanismos moleculares subjacentes, a fim de descobrir novos biomarcadores com utilidade clinica. Este artigo de revisão resume o papel dos glicanos a as alterações da glicosilação ao longo do processo de desenvolvimento e progressão do cancro gástrico. São discutidos neste artigo as aplicações clínicas destas alterações de glicosilação. Na foto, Salomé Pinho e Celso A. Reis, investigadores do IPATIMUP.

 

 

Autores e afiliações:

Glycoproteomic Analysis of Serum from Patients with Gastric Precancerous Lesions

The study identified proteins with abnormal glycosylation in the serum of patients with pre-neoplastic gastric lesions, indicating the possibility of non-invasive diagnosis in this context. The serum glycoproteome approach identified, among others, plasminogen as a carrier of aberrant glycoforms.

 

Journal:
Journal of Proteome Research

 

Salomé Pinho (IPATIMUP) distinguished by EACR with «Young Investigator Award»

Salome Pinho (IPATIMUP) distinguished by EACR with 'Young Investigator Award'

Salomé Pinho was awarded with the «Young Investigator Award» by the EACR for her contribution for the identification of a novel regulatory system of a protein that is determinant in the process of gastric cancer development and progression.

This work was recently published in Biochimica et Biophysica Acta (Pinho SS et al BBA 2012 [Epub ahead of print]) and PLoS ONE (Pinho SS et al. PLoS One. 2012;7(3):e33191) journals.


Abstract

Salomé Pinho (Ipatimup) distinguida pela EACR com o «Young investigator Award»

Salomé Pinho (IPATIMUP) distinguida pela EACR com o «Young investigator Award»

Salomé Pinho was awarded with the “Young Investigator Award” by the EACR for her contribution for the identification of a novel regulatory system of a protein that is determinant in the process of gastric cancer development and progression.

This work was recently published in Biochimica et Biophysica Acta (Pinho SS et al BBA 2012 [Epub ahead of print]) and PLoS ONE (Pinho SS et al. PLoS One. 2012;7(3):e33191) journals.


Abstract

Análise do glicoproteoma sérico de doentes com lesões gástricas pré-neoplásicas

Este estudo permitiu identificar proteínas com glicosilação anómala no soro de doentes com lesões gástricas pré-neoplásicas, abrindo a possibilidade de diagnóstico não invasivo nesse contexto. A abordagem, de estudo do glicoproteoma sérico, identificou entre outras proteínas o plasminogénio como sendo «portador» de formas de glicosilação aberrante. 

 

Revista:
Journal of Proteome Research